baber/WOPTO huggingface dataset:
Patent NZ-529981-A (NZ)
Title: Methods of managing the transfer and use of data by a RFID reader
Inventor: EISENBERG PETER MARK
Filed: 2001-06-05
Abstract: A method of transferring and using information comprises: (a) obtaining information related to a plurality of items from an existing database; (b) reformatting the information in a desired manner to facilitate the use of the information by an RFID reader; (c) exporting the information to a database stored on a data storage device and (d) using the information on the data storage device with an RFID reader in conjunction with the interrogation of RFID tags associated with the items. The existing database includes information correlating the items to item identifiers which can be barcodes or can be characters or handwriting.
Patent NZ-530862-A (NZ)
Title: Anti-Rotation foot for strainer post
Inventor: SMITH MICHAEL ALEXANDER
IPC: E04H17/22
Filed: 2004-01-30
Abstract: A fence post footing comprising a steel plate having a flat base and a vertical panel folded along one side of the base to form an "L" profile footing, a bendable tab formed in the side of the base opposite the panel by slots in the base, and apertures provided in each of the vertical panel, base and tab to facilitate nailing of the footing to the flat bottom and sides of a post.
Patent NZ-532513-A (NZ)
Title: Liquid container with applicator
Inventor: TSAUR GARRY
IPC: A45D34/00
Filed: 2004-04-22
Abstract: A liquid container with an applicator comprises an elongated tubular container (1) sealed at both ends and having a prescribed frangible opening means (11) provided near its one end thereof, an elongated slender inner tube (2) inserted into the container and fixedly conjoining its one end with that of the container, a liquid (3) filled in the container in sealed state, a tubular stump (4) with its one end conjoined to the end of the container where the opening means being provided, while its other end thereof being wrapped with an enclosure(5), wherein when the container is opened by the opening means, the liquid content is still unable to flow out automatically unless the open port of the container touches the enclosure to break the surface tension of the liquid content thereby inducing the liquid content to flow out along the inner tube to be absorbed by the enclosure.
Patent NZ-533495-A (NZ)
Title: Isolated hex1 promoter from fungal species Trichoderma reesei and proteomic method for obtaining such
Inventor: NEVALAINEN HELENA
IPC: C12Q1/68
Filed: 2002-12-13
Abstract: Disclosed is an isolated hex1 promoter having disclosed nucleotide sequence from the fungal species Trichoderma reesei. Further provided is a proteomic method for obtaining an isolated hex1 promoter from said species and uses of the isolated promoter.
Patent NZ-533821-A (NZ)
Title: Orodispersible pharmaceutical composition comprising perindopril
Inventor: WUTHRICH PATRICK
IPC: A61P9/00
Filed: 2003-01-22
Abstract: A solid orodispersible pharmaceutical composition of perindopril is disclosed, wherein the composition comprises perindopril or one of the pharmaceutically-acceptable salts thereof and granules consisting of co-dried lactose and starch. This solid orodispersible pharmaceutical composition is suitable for use in the treatment of arterial hypertension and heart failure.
Patent NZ-534259-A (NZ)
Title: A protein with homology to cysteine-rich secretory protein (CRISP) inhibitor
Inventor: AGARWAL PANKAJ
IPC: C12N15/09
Filed: 2001-09-13
Abstract: An isolated polypeptide comprises the sequence of SEQ ID NO:25, is encoded by a polynucleotide comprising the sequence SEQ ID NO.69, or is the polypeptide sequence of the of the gene sbg1002620TIb Cysteine-rich secretory protein (CRISP) inhibitor. Also described are vectors, recombinant host cells and processes of producing the polypeptide.
Patent NZ-537160-A (NZ)
Title: Medical applications of adaptive learning systems
Inventor: REEVE ANTHONY EDMUND
Filed: 2002-03-15
Abstract: A system for selecting a set of distinguishing over-expressed or under-expressed genes linked to one or more conditions comprises: a) an input capable of receiving one or more sets of gene expression data categorised into one or more predetermined conditions; b) a neural network module adapted to receive the gene expression data and one or more predetermined conditions; c) an extraction component for extracting rules from the rule base layer and d) an identifier for identifying over-expressed or under-expressed genes from the extracted rules, which genes represent a set of distinguishing over-expressed or under-expressed genes linked to the one or more conditions. The neural network module comprises an input layer comprising one or more input nodes configured to receive gene expression data; a rule base layer comprising one or more rule nodes; an output layer comprising one or more output nodes configured to output one or more conditions; and an adaptive component configured to extract one or more rules from the rule base layer representing relationships between the gene expression data and the one or more conditions. The adaptive component is arranged to aggregate selected two or more rule nodes in the rule base layer based on the input data. The rules represent the relationships between the gene expression data and the one or more conditions.
Patent NZ-538377-A (NZ)
Title: Internet based delivery system for delivering auxiliary content such as advertisements
Inventor: PANARA TIZIANO
IPC: G06Q30/00
Filed: 2003-07-22
Abstract: An auxiliary content selection system comprises a content database of records and a content selection means in communication with the content database. Each record defines an item of auxiliary content, and a broadcast space for delivery of the associated auxiliary content item. The broadcast space is segregated into time slots. The content selection means in communication with the content database selects one of the items in accordance with a correlation between the broadcast spaces, a time instant of issuance of a request from a client terminal for the auxiliary content and a web site accessed by the client terminal.
Patent NZ-539408-A (NZ)
Title: Quinazoline derivatives as SRC tyrosine kinase inhibitors for treating solid tumours
Inventor: PLE PATRICK
IPC: C07D491/04
Filed: 2003-10-29
Abstract: Disclosed herein are quinazoline derivatives of formula (I), wherein Z is an O, S, SO, SO2, N(R2) or C(R2)2 group wherein each R2 group is hydrogen or (1-8C) alkyl, m is 1, 2 or 3, each R1 group is selected from halogeno, (1-8C) alkyl, (1-6C) alkoxy and any of the other substituents defined in the specification, n is 0, 1, 2 or 3, and each R3 group is selected from halogeno, (1-8C) alkyl, (1-6C) alkoxy and any of the other substituents defined in the specification, or pharmaceutically-acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an anti-invasive agent in the containment and/or treatment of solid tumour disease.
Patent NZ-540465-A (NZ)
Title: Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
Inventor: WADDELL SHERMAN T
IPC: C07D413/02
Filed: 2003-12-16
Abstract: Disclosed is a compound of structural formula (I) wherein the substituents are as defined in the specification. Compounds of the type disclosed are useful in the treatment of conditions such as hyperglycaemia, insulin resistance, Type 2 diabetes, lipid disorders, obesity, atherosclerosis, Metabolic Syndrome, hypertension, anxiety, cognitive impairment and depression.
Patent NZ-541912-A (NZ)
Title: Nasal mask assembly
Inventor: GING ANTHONY MICHAEL
IPC: A61M16/06
Filed: 2004-02-20
Abstract: Headgear for use with a respiratory mask is disclosed. The headgear has first and second straps adapted to be provided to a mask frame of the mask, where each of the first and second straps includes a yoke. Each yoke is constructed and arranged to accommodate a pre-adult patient of a small sized adult patient.
Patent NZ-546755-A (NZ)
Title: Wastewater purification method using an electrocoagulation cell
Inventor: VOLPE PATRICK JOHN
IPC: C02F5/00
Filed: 2004-09-23
Abstract: This discloses a method of purifying wastewater which includes the following steps: (i) passing the wastewater through an electrocoagulation cell 5 which comprises a plurality of reaction plates or electrodes 6 disposed within the cell 5 and spaced apart from each other, whereby the wastewater is treated by passing an electric current through the wastewater producing an electrochemical reaction which generates a floc in the electro coagulation cell 5, whereby the floc binds or absorbs impurities present in the wastewater; (ii) passing the wastewater containing the floc having bound thereto the impurities into a coagulation tank or settling tank whereby froth and oil is discharged from the coagulation tank or settling tank at the top thereof through an adjacent conduit and the floc is discharged from the tank to produce purified water; (iii) using the purified water for cleaning or other purposes to produce wastewater; and (iv) recycling the wastewater back to the electrocoagulation cell 5.
Patent NZ-551001-A (NZ)
Title: Projectile featuring marking of the point of impact
Inventor: HAESELICH DETLEF
IPC: F42B8/00
Filed: 2005-04-08
Abstract: A projectile (2) has a projectile body (4) that includes a hollow ogive (6) that bursts upon striking the target into which marking material (13) is inserted. The marking material is released when the projectile strikes the target and the ogive bursts. The marking material is covered by an additional protective cap (14) that breaks when the projectile bursts on the target and an intermediary space (15) is left between the ogive and the additional protective cap. The projectile can be a practice round. The marking material can be a dye powder.
Patent NZ-552283-A (NZ)
Title: New compounds useful for the treatment of obesity, type II diabetes and CNS disorders
Inventor: JOHANSSON GARY
IPC: A61P25/00
Filed: 2003-06-19
Abstract: The disclosure relates to compounds of the formula (I), particularly to substituted phenyl-sulfonyl-piperazin-thieno-pyridine hydrochloride derivative compounds, wherein D, P, W, X, Y and R3 are as defined in the specification; to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes, and/or CNS disorders, to achieve reduction of body weight and of body weight gain.
Patent NZ-553618-A (NZ)
Title: Monument assembly and method of installation
Inventor: BURMAN ALLAN
IPC: E04H13/00
Filed: 2005-07-26
Abstract: An inscription plate and a monument assembly having an inscription plate are disclosed. The inscription plate is formed by a pair of metal sheets, each having indicia in the form of openings formed thereon. The indicia in both metal sheets is aligned with each other and a translucent, transparent, or coloured, intermediate sheet is interposed between each metal sheet.
Patent NZ-561795-A (NZ)
Title: Heterocyclic derivatives as opioid modulators
Inventor: BRESLIN HENRY J
IPC: C07D211/60
Filed: 2003-04-17
Abstract: Disclosed is a compound of formula (II) and pharmaceutically acceptable enantiomers, diastereomers and salts thereof, wherein the Y is CH or a nitrogen atom, R30 and R31 are independently selected from the group consisting of C1-6alkyl, C1-6alkoxy substituted with hydroxy and amino, and halogen and wherein the remaining variables are as defined in the specification.
Patent NZ-564038-A (NZ)
Title: Yarns containing siliconized microdenier polyester fibers
Inventor: PATTERSON IAN
IPC: D03D15/58
Filed: 2006-06-28
Abstract: A yarn comprises siliconised micro-denier polyester fibres and non-siliconised macro-denier fibres, where the blending ratio by weight of the siliconised micro-denier polyester fibres and non-siliconised macro-denier fibres ranges between 10% to 90% of the total weight of the yarn and correspondingly the blending ratio by weight of the non-siliconised macro-denier fibres and siliconised micro-denier polyester fibres will range between 10% to 90% of the total weight of the yarn.
Patent NZ-576855-A (NZ)
Title: Diagnosis and treatment of cancer using anti-ereg antibody
Inventor: ABURATANI HIROYUKI
IPC: A61K51/00
Filed: 2007-10-12
Abstract: Disclosed is a monoclonal antibody with specific binding sites designed to inhibit cell proliferation in cells expressing epiregulin (EREG) protein by inducing cytotoxic activity in the cell. Expression of an EREG is enhanced at a protein level in gastrointestinal cancer, pulmonary adenocarcinoma, pancreatic cancer, gastric cancer or renal cancer. Further disclosed are pharmaceuticals involving minibodies and various chemotherapeutic agents.
Patent NZ-578581-A (NZ)
Title: A method for recovery of high purity carbon dioxide
Inventor: FIND RASMUS
IPC: C01B32/50
Filed: 2008-01-16
Abstract: Disclosed is a method for the recovery of high purity carbon dioxide from a gaseous source comprising the steps of: a) feeding a gas comprising carbon dioxide, oxygen, N2, nitrogen oxides, and optionally sulphurous compounds and volatile organic contaminants into an absorption column, b) absorbing the gas in an absorbing agent, by which the gas is separated into a carbon dioxide-lean gas and a carbon dioxide-rich liquid, c) pressurising and heating the liquid obtained in step b in order to provide pressurised and heated liquid, d) separating by means of flashing the liquid obtained in step c into a N2-, NOx- and oxygen-rich gas and a N2-, NOx- and oxygen depleted liquid leaving the flash column, e) pressurising the liquid leaving the flash column in step d in order to provide a pressurised liquid, f) separating the liquid obtained in step e into a carbon dioxide rich stripper off gas and a carbon dioxide-depleted liquid by means of stripping in a stripper column, g) cooling the stripper off gas obtained in step f in order to provide a cooled gas.
Patent NZ-586928-A (NZ)
Title: Aqueous accelerator mixture
Inventor: WEIBEL MARTIN
IPC: C04B28/02
Filed: 2008-12-04
Abstract: Disclosed is an accelerator which is present as an aqueous mixture which contains the following:(a) aluminium in oxidation state 3 (b) sulphate, (c) fluoride and/or (semi)metal fluoro complexes, (d) magnesium silicate.
Patent NZ-588266-A (NZ)
Title: Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
Inventor: BERGER RICHARD
IPC: C07D401/12
Filed: 2009-04-02
Abstract: Provided is a hydroxymethyl pyrrolidine compound of Formula (Ia), with defined substituents. The compound is useful for treating diseases mediated by the activation of beta3-adrenoreceptor, including overactive bladder, incontinence and other similar diseases.
Patent NZ-590756-A (NZ)
Title: Insecticidal compounds
Inventor: RENOLD PETER
IPC: C07D413/12
Filed: 2009-07-24
Abstract: Disclosed is a 4-phenyl 5-trihalomethyl isoxazol amide of formula (I) wherein the variables are defined in the specification for combating and controlling insects, acarines, nematodes or molluscs
Patent NZ-597770-A (NZ)
Title: Floating mechanism loading vehicle provided with double shafts and eight wheels for pavement accelerated loading test
Inventor: FENG JINXIANG
IPC: E01C23/01
Filed: 2010-05-31
Abstract: 597770 A floating mechanism is disclosed for a road pavement accelerated load testing vehicle. The vehicle is provided with double shafts (5) and eight wheels. The floating mechanism comprises front and rear rotating shafts (5) with two loading steel wheels (3) and two backhaul steel wheels (2) mounted on each shaft (5). The loading steel wheels (3) are fixed on the rotating shafts (5) and the backhaul steel wheels (2) are rotatable around the rotating shafts (5). The floating mechanism further comprises a loading rail (4) on which the loading steel wheels (3) run during a loading rolling course and a backhaul rail (1) on which the backhaul steel wheels (2) run during an unloading backhaul course.
Patent NZ-598733-A (NZ)
Title: Pea line dlsc7v0955
Inventor: WEBSTER DAVID
IPC: A01H5/10
Filed: 2012-03-12
Abstract: Disclosed is a seed or plant of pea line DLSC7V0955, a sample of seed of said line having been deposited under ATCC Accession Number PTA-11600.
Patent NZ-607636-A (NZ)
Title: Controlled release compositions and their methods of use
Inventor: AL ALAWI FADIL
IPC: A61K9/52
Filed: 2012-02-27
Abstract: 607636 Disclosed is a composition, the composition including a therapeutically effective amount of at least one active agent, and a base configured to provide a controlled release of the at least one active agent, the base including, an amount of colloidal silica; at least one oil; and at least one surfactant, wherein the viscosity of the composition is below 1000 mPas at a shear rate of 100 1/s and at a temperature of 20°C. Also disclosed is the method for preparing the composition, the method of treating a non-human animal for mastitis and the use of the composition for the manufacture of a medicament for treating mastitis.
Patent NZ-610474-A (NZ)
Title: Methods to predict clinical outcome of cancer
Inventor: CRONIN MAUREEN T
IPC: C12Q1/68
Filed: 2010-11-19
Abstract: Disclosed is a method for predicting the clinical outcome of a human patient diagnosed with breast cancer comprising: (a) measuring a level of an RNA transcript of ENO1, or an expression product thereof, in a tissue sample obtained from a tumour of the patient; (b) normalising the level of the RNA transcript of ENO1, or an expression product thereof, to obtain a normalised ENO1expression level; (c) comparing the normalised ENO1 gene expression level to a normalised ENO1 expression level obtained from a breast cancer reference set; and (d) determining that the patient has a decreased likelihood of good prognosis if the normalised ENO1 expression level is increased.
Patent NZ-611485-A (NZ)
Title: Modulators of atp-binding cassette transporters
Inventor: YANG XIAOQING
IPC: A61K31/404
Filed: 2007-04-09
Abstract: Disclosed herein is a method for the preparation of an amide indole derivative compound of formula (Id) e.g. 1-(Benzo[d][1,3]dioxol-5-yl)-N-(2-(2-methyl-4-(1H-tetrazol-5-yl)butan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide or a pharmaceutically acceptable salt thereof for treating or lessening the severity of male infertility or pancreatic insufficiency, wherein the variables R1, R2, A, B and n shown in formula (Id) are as defined in the specification, and wherein the method comprises coupling the carboxylic acid moiety with an amine moiety as defined and shown in the specification.
Patent NZ-613613-A (NZ)
Title: A portable animal handling system and method of using same
Inventor: FAGAN ROBIN CHRISTOPHER FELTRIM
IPC: B62D63/08
Filed: 2012-08-16
Abstract: 613613 And animal handling system has a chassis with at least two wheels and fore and aft sections horizontally pivotable to chassis so as to be pivoted back over chassis to reduce footprint and for transport of device. In the deployed condition the system can be used for sheep with clamping on the chassis after a sheep moves up a fore section, and can then depart via an aft section having an open framework with bars spaced apart.
Patent NZ-712403-A (NZ)
Title: Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration
Inventor: GERHART WILLIAM
IPC: A61P11/08
Filed: 2010-06-09
Abstract: The disclosure relates to the use R,R-formoterol for treating a patient having chronic obstructive pulmonary disease (COPD), comprising administering to the patient, with a high efficiency nebulizer, a dose of a R,R-formoterol (arformoterol) at a dose of 1 µg to about 15 µg. The treatment produces clinically meaningful bronchodilation for at least 24 hours.
Patent NZ-713736-A (NZ)
Title: Synergistic fungicidal mixtures for fungal control in cereals
Inventor: YAO CHENGLIN
IPC: A01P3/00
Filed: 2010-10-06
Abstract: A synergistic fungicidal mixture comprising a fungicidally effective amount of a compound of Formula II or III and at least one fungieide selected from the group consisting of prothioconazole, azoxystrobin, pyraclostrobin, penthiopyrad, isopyrazam, bixafen, boscalid, prochloraz, and chlorothalonil. The compounds of formulae II and III are: [(3S,7R)-3-[(3-acetyloxy-4-methoxypyridine-2-carbonyl)amino]-8-benzyl-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate; and [(3S,7R)-3-[[3-(acetyloxymethoxy)-4-methoxypyridine-2-carbonyl]amino]-8-benzyl-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate
Patent NZ-714545-A (NZ)
Title: Steering mechanism for an articulated vehicle
Inventor: MOFFETT ROBERT
IPC: E02F9/08
Filed: 2014-06-16
Abstract: An articulated vehicle [10] has a first body section [12], a second body section [14], and an elongate projection [22] projecting from the first body section [12] towards the second body section [14]. A pair of steering cylinders [36, 34] are mounted such that they are partially or wholly disposed in or on the elongate projection [22], and are disposed one above the other so they overlap vertically, thereby narrowing the projection at the end nearer the first body section [12] and allowing the second body section [14] to be rotated closer to the centre line. A rotatable shaft [40] of the second body section [14] is mounted towards the far end of the elongate projection [22] and is steered by a pair of linkages such as chains [42, 44], each of which is connected to the shaft [40] and to a respective one of the steering cylinders [36, 34]. The chains [42, 44] wrap around the shaft [40] with a circumferential overlap, though they are spaced vertically. This circumferential overlap allows steering angles significantly in excess of 180° to be achieved.
Patent NZ-719771-A (NZ)
Title: Methods and compositions for sustained immunotherapy
Inventor: SANTAMARIA PEDRO
IPC: A61P37/06
Filed: 2014-11-03
Abstract: This disclosure provides compositions and methods for promoting the formation, expansion and recruitment of TR1 cells and /or Breg cells in an antigen-specific manner and treating autoimmune diseases and disorders in a subject in need thereof. The compositions comprise antigen-MHC class II-nanoparticle complexes. In an embodiment the antigen-MHC class II complex is linked to the nanoparticle via a PEG linker. PEG functionalized iron oxide nanoparticles can be prepared by thermally decomposing iron acetyl acetonate in the presence of functionalized PEG molecules, with or without benzyl ether. This simplifies the production of these nanoparticles.
Patent NZ-720289-A (NZ)
Title: Equipment for processing fibrous material
Inventor: VAN DER LEEST FRÉ
IPC: D01G15/46
Filed: 2014-11-26
Abstract: Equipment for processing fibrous material with reduced attrition rates comprising a carder (45) having a movable carding surface, and a feed device(40 for feeding fibrous material to the carder. The feed device comprises a slide surface (41) disposed substantially tangentially to the carding surface and arranged to direct fibrous material primarily under the influence of gravity into contact with the carder. A deflector (410) at the end region is shaped to direct fibrous material obliquely on to the carding surface. (Fig. 1)